ReviewFrontiers in oncology2022
Potential of histone deacetylase inhibitors for the therapy of ovarian cancer.
Fengyi Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ReviewFrontiers in oncology2022
Fengyi Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.